Home
/
PANACEA LIFE SCIENCES HOLDINGS, INC.
/
Financials
/
Quarterly
PANACEA LIFE SCIENCES HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PANACEA LIFE SCIENCES HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Dec 31, 2022
$2.30M
Nov 14, 2023
Q1
2022
Mar 31, 2022
$466.5K
May 13, 2022
Q3
2021
Sep 30, 2021
$588.0K
Dec 20, 2021
Q2
2021
Jun 30, 2021
$313.5K
Dec 20, 2021
Q1
2022
Mar 31, 2021
$512.1K
May 13, 2022
Q3
2021
Sep 30, 2020
$1.34M
Dec 20, 2021
Q2
2021
Jun 30, 2020
$6.16M
Dec 20, 2021
Q3
2020
Mar 31, 2020
$836.0K
Nov 18, 2020
Q1
2021
Mar 31, 2020
$836.0K
May 27, 2021
Q2
2020
Mar 31, 2020
$836.0K
Aug 19, 2020
Q3
2020
Dec 31, 2019
$345.7K
Nov 18, 2020
Q2
2020
Dec 31, 2019
$345.7K
Aug 19, 2020
Q2
2020
Sep 30, 2019
$60.2K
Aug 19, 2020
Q3
2020
Sep 30, 2019
$60.2K
Nov 18, 2020
Q3
2020
Jun 30, 2019
$60.2K
Nov 18, 2020
Q2
2020
Jun 30, 2019
$139.7K
Aug 19, 2020
Q1
2020
Mar 31, 2019
$16.0K
Jun 29, 2020
Q3
2019
Sep 30, 2018
$0
Nov 14, 2019
Q2
2019
Jun 30, 2018
$0
Aug 14, 2019
Q1
2019
Mar 31, 2018
$0
May 20, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
$1.06M
May 6, 2024
Q3
2023
Sep 30, 2023
$347.9K
Nov 14, 2023
Q2
2023
Jun 30, 2023
$399.1K
Aug 15, 2023
Q1
2024
Mar 31, 2023
$677.5K
May 6, 2024
Q3
2023
Sep 30, 2022
$366.2K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$469.5K
Aug 15, 2023
Q1
2023
Mar 31, 2022
$466.5K
May 12, 2023
Q3
2022
Sep 30, 2021
$588.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$313.5K
Aug 15, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
($1.45M)
May 6, 2024
Q3
2023
Sep 30, 2023
($2.15M)
Nov 14, 2023
Q2
2023
Jun 30, 2023
($1.86M)
Aug 15, 2023
Q1
2024
Mar 31, 2023
($1.79M)
May 6, 2024
Q3
2023
Sep 30, 2022
($2.69M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.96M)
Aug 15, 2023
Q1
2023
Mar 31, 2022
($2.78M)
May 12, 2023
Q3
2022
Sep 30, 2021
($3.09M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
$27.2K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$370.7K
May 13, 2022
Q3
2021
Sep 30, 2020
($3.78M)
Dec 20, 2021
Q2
2021
Jun 30, 2020
$655.2K
Dec 20, 2021
Q3
2020
Jun 30, 2020
($1.68M)
Nov 18, 2020
Q1
2021
Mar 31, 2020
($2.82M)
May 27, 2021
Q3
2020
Mar 31, 2020
($2.82M)
Nov 18, 2020
Q2
2020
Mar 31, 2020
($2.82M)
Aug 19, 2020
Q2
2020
Dec 31, 2019
($10.02M)
Aug 19, 2020
Q3
2020
Dec 31, 2019
($10.02M)
Nov 18, 2020
Q2
2020
Sep 30, 2019
($2.03M)
Aug 19, 2020
Q3
2020
Sep 30, 2019
($2.03M)
Nov 18, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
($1.06M)
May 6, 2024
Q3
2023
Sep 30, 2023
($1.41M)
Nov 14, 2023
Q2
2023
Jun 30, 2023
($1.07M)
Aug 15, 2023
Q1
2024
Mar 31, 2023
($1.29M)
May 6, 2024
Q3
2023
Sep 30, 2022
($1.39M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.24M)
Aug 15, 2023
Q1
2023
Mar 31, 2022
($1.65M)
May 12, 2023
Q3
2022
Sep 30, 2021
($1.26M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.44M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.09M)
May 13, 2022
Q3
2021
Sep 30, 2020
($3.35M)
Dec 20, 2021
Q2
2021
Jun 30, 2020
$802.6K
Dec 20, 2021
Q3
2020
Mar 31, 2020
($2.63M)
Nov 18, 2020
Q2
2020
Mar 31, 2020
($2.63M)
Aug 19, 2020
Q1
2021
Mar 31, 2020
($2.63M)
May 27, 2021
Q3
2020
Dec 31, 2019
($10.67M)
Nov 18, 2020
Q2
2020
Dec 31, 2019
($10.67M)
Aug 19, 2020
Q2
2020
Sep 30, 2019
($2.02M)
Aug 19, 2020
Q3
2020
Sep 30, 2019
($2.02M)
Nov 18, 2020
Q2
2020
Jun 30, 2019
($1.11M)
Aug 19, 2020